SINGAPORE (Oct 23): Specialty pharmaceutical firm iX Biopharma announced Monday that it has secured a European patent for its WaferiX drug delivery technology.

The grant of the patent allows iX Biopharma to obtain validation and coverage in the countries that currently make up the European Union (EU).

Already, iX Biopharma has proceeded to apply for coverage in 16 EU nations: Germany, France, United Kingdom, Italy, Spain, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, Austria, Norway, Denmark, Ireland, and Finland.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook